BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9085346)

  • 1. Ischaemic cardiac hyperaemia: role of nitric oxide and other mediators.
    Gryglewski RJ; Chlopicki S; Niezabitowski P; Jakubowski A; Lomnicka M
    Physiol Res; 1996; 45(4):255-60. PubMed ID: 9085346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial reactive hyperaemia in perfused guinea pig heart.
    Gryglewski RJ; Chłopicki S; Niezabitowski P
    Pol J Pharmacol; 1995; 47(5):479-83. PubMed ID: 8868144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial control of coronary flow in perfused guinea pig heart.
    Gryglewski RJ; Chlopicki S; Niezabitowski P
    Basic Res Cardiol; 1995; 90(2):119-24. PubMed ID: 7646416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischaemic preconditioning changes the pattern of coronary reactive hyperaemia in the goat: role of adenosine and nitric oxide.
    Gattullo D; Linden RJ; Losano G; Pagliaro P; Westerhof N
    Cardiovasc Res; 1999 Apr; 42(1):57-64. PubMed ID: 10434996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide is a major mediator in reactive hyperaemia evoked by a brief coronary occlusion in the guinea pig heart.
    Chłopicki S; Gryglewski RJ
    Eur J Pharmacol; 1993 Sep; 241(1):117-20. PubMed ID: 7693491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation.
    Dick GM; Bratz IN; Borbouse L; Payne GA; Dincer UD; Knudson JD; Rogers PA; Tune JD
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2371-81. PubMed ID: 18375717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of adenosine and prostacyclin in coronary flow regulation after myocardial ischemia.
    Stangl V; Frank TM; Schrör K; Stangl K; Baumann G; Felix SB
    Eur J Pharmacol; 1999 Jul; 377(1):43-50. PubMed ID: 10448924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.
    Bradamante S; Barenghi L; Piccinini F; Bertelli AA; De Jonge R; Beemster P; De Jong JW
    Eur J Pharmacol; 2003 Mar; 465(1-2):115-23. PubMed ID: 12650840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial reactive hyperemia in experimental chronic heart failure: evidence for the role of K+ adenosine triphosphate-dependent channels and cyclooxygenase activity.
    Viau S; Fontaine E; Véronneau M; Jasmin G; Dumont L
    J Card Fail; 1997 Sep; 3(3):207-15. PubMed ID: 9330129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of nitric oxide and adenosine in the regulation of coronary conductance in the basal state and during reactive hyperemia.
    Otomo J; Nozaki N; Tomoike H
    Jpn Circ J; 1997 May; 61(5):441-9. PubMed ID: 9192244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine endogenously released during early reperfusion mitigates postischemic myocardial dysfunction by inhibiting platelet adhesion.
    Seligmann C; Kupatt C; Becker BF; Zahler S; Beblo S
    J Cardiovasc Pharmacol; 1998 Jul; 32(1):156-63. PubMed ID: 9676736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of adenosine metabolism increases myocardial interstitial adenosine concentrations and coronary flow.
    Ely SW; Matherne GP; Coleman SD; Berne RM
    J Mol Cell Cardiol; 1992 Nov; 24(11):1321-32. PubMed ID: 1479623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia.
    Goulielmos NV; Enayat ZE; Sheridan DJ; Cohen H; Flores NA
    Cardiovasc Res; 1995 Nov; 30(5):788-98. PubMed ID: 8595628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts.
    du Toit EF; McCarthy J; Miyashiro J; Opie LH; Brunner F
    Br J Pharmacol; 1998 Mar; 123(6):1159-67. PubMed ID: 9559900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart.
    Peart J; Matherne GP; Cerniway RJ; Headrick JP
    Cardiovasc Res; 2001 Oct; 52(1):120-9. PubMed ID: 11557240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection by cyclosporine A in experimental ischemia and reperfusion--evidence for a nitric oxide-dependent mechanism mediated by endothelin.
    Massoudy P; Zahler S; Kupatt C; Reder E; Becker BF; Gerlach E
    J Mol Cell Cardiol; 1997 Feb; 29(2):535-44. PubMed ID: 9140813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide in reactive hyperemia of the guinea pig heart.
    Kostic MM; Schrader J
    Circ Res; 1992 Jan; 70(1):208-12. PubMed ID: 1309316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of nitric oxide and prostanoids to the cardiac electrophysiological and coronary vasomotor effects of diadenosine polyphosphates.
    Stavrou BM; Sheridan DJ; Flores NA
    J Pharmacol Exp Ther; 2001 Aug; 298(2):531-8. PubMed ID: 11454914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative participation of adenosine and endothelium derived mediators in coronary reactive hyperemia in the dog.
    Macho P; Domenech R; Penna M
    Biol Res; 1995; 28(2):165-71. PubMed ID: 9251746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of histamine in the regulation of coronary circulation.
    Kostić MM; Jakovljević VL
    Physiol Res; 1996; 45(4):297-303. PubMed ID: 9085353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.